Neurofibromatosis Midwest
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 269,667 | 258,981 | 10,686 | 12.7 | 29% |
| 2012 | 282,332 | 321,971 | −39,639 | 8.8 | 33% |
| 2013 | 266,362 | 305,366 | −39,004 | 7.8 | 39% |
| 2014 | 455,646 | 341,762 | 113,884 | 11.0 | 57% |
| 2015 | 269,672 | 244,361 | 25,311 | 16.7 | 48% |
| 2016 | 260,197 | 250,490 | 9,707 | 17.0 | 49% |
| 2017 | 248,339 | 266,338 | −17,999 | 15.1 | 41% |
| 2018 | 277,690 | 323,157 | −45,467 | 10.5 | 36% |
| 2019 | 257,121 | 209,751 | 47,370 | 19.6 | 41% |
| 2020 | 179,571 | 214,976 | −35,405 | 17.5 | 40% |
| 2021 | 209,965 | 175,928 | 34,037 | 23.7 | 48% |
| 2022 | 220,690 | 218,142 | 2,548 | 17.3 | 39% |
| 2023 | 241,223 | 262,588 | −21,365 | 13.4 | 41% |
In its most recent public year (2023), this organization spent $21,365 more than it brought in. Its reserves stood at about 13.4 months of spending. Staff pay was 41% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Neurofibromatosis Midwest's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works